Manulife (Manufacturers Life Insurance)
GPCR icon

Manulife (Manufacturers Life Insurance)’s Structure Therapeutics GPCR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.53M Buy
114,814
+18,427
+19% +$1.26M ﹤0.01% 1113
2025
Q4 		$6.53M Buy
96,387
+67,855
+238% +$2.77M 0.01% 1071
2025
Q3 		$799K Sell
28,532
-12,257
-30% -$244K ﹤0.01% 1981
2025
Q2 		$846K Buy
40,789
+52
+0.1% +$1.14K ﹤0.01% 1903
2025
Q1 		$705K Sell
40,737
-17,505
-30% -$429K ﹤0.01% 1969
2024
Q4 		$1.58M Sell
58,242
-28,600
-33% -$1.01M ﹤0.01% 1673
2024
Q3 		$3.81M Sell
86,842
-7,528
-8% -$291K ﹤0.01% 1324
2024
Q2 		$3.71M Buy
94,370
+32,839
+53% +$1.35M ﹤0.01% 1290
2024
Q1 		$2.64M Buy
61,531
+8,327
+16% +$351K ﹤0.01% 1422
2023
Q4 		$2.17M Sell
53,204
-1,882
-3% -$108K ﹤0.01% 1445
2023
Q3 		$2.78M Buy
55,086
+14,455
+36% +$466K ﹤0.01% 1335
2023
Q2 		$1.69M Buy
+40,631
New +$1.14M ﹤0.01% 1460

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s GPCR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Structure Therapeutics (GPCR) stake by 19% in Q1 2026, buying an estimated $1.26M and bringing the position to 114,814 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Manulife (Manufacturers Life Insurance) first reported a position in GPCR in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.53M in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 114,814 shares of Structure Therapeutics worth $5.53M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 18,427 Structure Therapeutics shares in Q1 2026, an estimated $1.26M.
  • Structure Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1113 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Structure Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Structure Therapeutics position peaked at $6.53M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.